261 related articles for article (PubMed ID: 25215891)
1. Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.
Yu Y; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Donald PJ; Chen AM
Laryngoscope; 2015 Mar; 125(3):608-14. PubMed ID: 25215891
[TBL] [Abstract][Full Text] [Related]
2. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.
Gensheimer MF; Liao JJ; Garden AS; Laramore GE; Parvathaneni U
Radiat Oncol; 2014 Nov; 9():255. PubMed ID: 25424729
[TBL] [Abstract][Full Text] [Related]
3. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
[TBL] [Abstract][Full Text] [Related]
4. The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.
Lee NCJ; Kelly JR; Park HS; Yarbrough WG; Burtness BA; Husain ZA
Pract Radiat Oncol; 2017; 7(5):e317-e321. PubMed ID: 28356201
[TBL] [Abstract][Full Text] [Related]
5. Selectively sparing the submandibular gland when level Ib lymph nodes are included in the radiation target volume: An initial safety analysis of a novel planning objective.
Varra V; Ross RB; Juloori A; Campbell S; Tom MC; Joshi NP; Woody NM; Ward MC; Xia P; Koyfman SA; Greskovich JF
Oral Oncol; 2019 Feb; 89():79-83. PubMed ID: 30732963
[TBL] [Abstract][Full Text] [Related]
6. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
7. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
[TBL] [Abstract][Full Text] [Related]
8. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
9. Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.
Tam M; Riaz N; Kannarunimit D; Peña AP; Schupak KD; Gelblum DY; Wolden SL; Rao S; Lee NY
Am J Clin Oncol; 2015 Aug; 38(4):343-7. PubMed ID: 26208401
[TBL] [Abstract][Full Text] [Related]
10. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
[TBL] [Abstract][Full Text] [Related]
11. Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review.
Robin TP; Gan GN; Tam M; Westerly D; Riaz N; Karam SD; Lee N; Raben D
Head Neck; 2016 Apr; 38(4):506-11. PubMed ID: 25482748
[TBL] [Abstract][Full Text] [Related]
12. Submandibular gland preservation during concurrent neck dissection and transoral surgery for oropharyngeal squamous cell carcinoma.
Howard BE; Hinni ML; Nagel TH; Chang YH; Cheng MR; Hayden RE
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):587-93. PubMed ID: 24449797
[TBL] [Abstract][Full Text] [Related]
13. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
Saarilahti K; Kouri M; Collan J; Kangasmäki A; Atula T; Joensuu H; Tenhunen M
Radiother Oncol; 2006 Mar; 78(3):270-5. PubMed ID: 16564589
[TBL] [Abstract][Full Text] [Related]
14. Effects of biodegradable hydrogel spacer injection on contralateral submandibular gland sparing in radiotherapy for head and neck cancers.
Rao AD; Coquia S; De Jong R; Gourin C; Page B; Latronico D; Dah S; Su L; Clarke S; Schultz J; Rosati LM; Fakhry C; Wong J; DeWeese TL; Quon H; Ding K; Kiess A
Radiother Oncol; 2018 Jan; 126(1):96-99. PubMed ID: 28985953
[TBL] [Abstract][Full Text] [Related]
15. Submandibular gland sparing when irradiating neck level IB in the treatment of oral squamous cell carcinoma.
Jackson WC; Hawkins PG; Arnould GS; Yao J; Mayo C; Mierzwa M
Med Dosim; 2019 Summer; 44(2):144-149. PubMed ID: 29778321
[TBL] [Abstract][Full Text] [Related]
16. Perifacial lymph node metastasis in the submandibular triangle of patients with oral and oropharyngeal squamous cell carcinoma with clinically node-positive neck.
Lim YC; Lee JS; Choi EC
Laryngoscope; 2006 Dec; 116(12):2187-90. PubMed ID: 17146394
[TBL] [Abstract][Full Text] [Related]
17. Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy.
Vergeer MR; Doornaert PA; Jonkman A; Kaanders JH; van den Ende PL; de Jong MA; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):682-8. PubMed ID: 20188492
[TBL] [Abstract][Full Text] [Related]
18. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; de Jong ME; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1216-24. PubMed ID: 20732761
[TBL] [Abstract][Full Text] [Related]
19. Submandibular gland-sparing intensity-modulated radiotherapy.
Mendenhall WM; Mendenhall CM; Mendenhall NP
Am J Clin Oncol; 2014 Oct; 37(5):514-6. PubMed ID: 22892434
[TBL] [Abstract][Full Text] [Related]
20. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
